Record Information |
---|
Version | 2.0 |
---|
Created at | 2022-03-17 21:20:33 UTC |
---|
Updated at | 2022-03-17 21:20:33 UTC |
---|
NP-MRD ID | NP0049938 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 25-Hydroxycholecalciferol |
---|
Description | Calcidiol, also known as 25(OH)D3 or rayaldee, belongs to the class of organic compounds known as vitamin d and derivatives. Vitamin D and derivatives are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. Thus, calcidiol is considered to be a secosteroid lipid molecule. A prehormone resulting from the oxidation of calciol in the liver, it is further hydroxylated in the kidney to give calcitriol, the active form of vitamin D3. Calcidiol is a drug which is used to treat vitamin d deficiency or insufficiency, refractory rickets (vitamin d resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis. Calcidiol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Calcidiol exists in all living organisms, ranging from bacteria to humans. Outside of the human body, Calcidiol is found, on average, in the highest concentration within a few different foods, such as milk (cow), other animal fats, and sausages and in a lower concentration in domestic pigs. Calcidiol has also been detected, but not quantified in, several different foods, such as wheats, syrups, lingonberries, bilberries, and other dish. This could make calcidiol a potential biomarker for the consumption of these foods. Calcidiol is a potentially toxic compound. 25-Hydroxycholecalciferol is found in Cucurbita pepo , Homo sapiens, Mus musculus and Solanum glaucophyllum. 25-Hydroxycholecalciferol was first documented in 1987 (PMID: 3040120). A hydroxycalciol that is calciol in which the hydrogen at position 25 has been replaced by a hydroxy group (PMID: 16886665) (PMID: 15585789) (PMID: 15384827) (PMID: 10469423) (PMID: 10089217) (PMID: 9543154). |
---|
Structure | C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol | ChEBI | (3S,5Z,7E)-9,10-Secocholesta-5,7,10-triene-3,25-diol | ChEBI | (5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol | ChEBI | 25(OH)D3 | ChEBI | 25-Hydroxycholecalciferol | ChEBI | 25-Hydroxyvitamin D3 | ChEBI | 3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol | ChEBI | Calcifediol | ChEBI | Calcifediol anhydrous | ChEBI | Calcifediolum | ChEBI | Rayaldee | ChEBI | (3S,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-3,25-diol | Kegg | (3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol | Generator | (3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol | Generator | 25-Hydroxy-cholecalciferol | HMDB | 5,6-cis-25-Hydroxyvitamin D3 | HMDB | 9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol | HMDB | Calderol | HMDB | Didrogyl | HMDB | Hidroferol | HMDB | 25 Hydroxyvitamin D3 | HMDB | Calcifediol, (3 beta,5E,7E)-isomer | HMDB | Monohydrate, 25-hydroxycholecalciferol | HMDB | 25-Hydroxycholecalciferol monohydrate | HMDB | Anhydrous, calcifediol | HMDB | Organon brand OF calcifediol | HMDB | 25 Hydroxyvitamin D 3 | HMDB | 25-Hydroxyvitamin D 3 | HMDB | Aventis brand OF calcifediol | HMDB | Calcifediol aventis brand | HMDB | Calcifediol organon brand | HMDB | Dedrogyl | HMDB | 25 Hydroxycholecalciferol | HMDB | 25 Hydroxycholecalciferol monohydrate | HMDB | Calcifediol faes brand | HMDB | Calcifediol, (3 alpha,5Z,7E)-isomer | HMDB | Faes brand OF calcifediol | HMDB | Calcidiol | MeSH |
|
---|
Chemical Formula | C27H44O2 |
---|
Average Mass | 400.6371 Da |
---|
Monoisotopic Mass | 400.33413 Da |
---|
IUPAC Name | (1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol |
---|
Traditional Name | 25-hydroxyvitamin D3 |
---|
CAS Registry Number | 19356-17-3 |
---|
SMILES | C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C |
---|
InChI Identifier | InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1 |
---|
InChI Key | JWUBBDSIWDLEOM-DTOXIADCSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as vitamin d and derivatives. Vitamin D and derivatives are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Vitamin D and derivatives |
---|
Direct Parent | Vitamin D and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Triterpenoid
- Tertiary alcohol
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Flanagan JN, Young MV, Persons KS, Wang L, Mathieu JS, Whitlatch LW, Holick MF, Chen TC: Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res. 2006 Jul-Aug;26(4A):2567-72. [PubMed:16886665 ]
- DeLuca HF: Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1689S-96S. [PubMed:15585789 ]
- Passadakis P, Ersoy F, Tam P, Memmos D, Siamopoulos K, Ozener C, Akcicek F, Camsari T, Ates K, Ataman R, Vlachojannis J, Dombros N, Utas C, Akpolat T, Bozfakioglu S, Wu GG, Karayaylali I, Arinsoy T, Stathakis C, Yavuz M, Tsakiris D, Dimitriades A, Yilmaz ME, Gultekin M, Karayalcin B, Challa A, Polat N, Oreopoulos DG: Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients. Adv Perit Dial. 2004;20:203-8. [PubMed:15384827 ]
- Park SB, Suh DH, Youn JI: A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis. Pediatr Dermatol. 1999 Jul-Aug;16(4):321-5. doi: 10.1046/j.1525-1470.1999.00084.x. [PubMed:10469423 ]
- Haden ST, Fuleihan GE, Angell JE, Cotran NM, LeBoff MS: Calcidiol and PTH levels in women attending an osteoporosis program. Calcif Tissue Int. 1999 Apr;64(4):275-9. doi: 10.1007/s002239900618. [PubMed:10089217 ]
- Gacad MA, Adams JS: Proteins in the heat shock-70 family specifically bind 25-hydroxyvitamin D3 and 17beta-estradiol. J Clin Endocrinol Metab. 1998 Apr;83(4):1264-7. doi: 10.1210/jcem.83.4.4725. [PubMed:9543154 ]
- Feingold KR, Williams ML, Pillai S, Menon GK, Halloran BP, Bikle DD, Elias PM: The effect of vitamin D status on cutaneous sterologenesis in vivo and in vitro. Biochim Biophys Acta. 1987 Sep 14;930(2):193-200. doi: 10.1016/0167-4889(87)90031-0. [PubMed:3040120 ]
- Kemmis CM, Salvador SM, Smith KM, Welsh J: Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J Nutr. 2006 Apr;136(4):887-92. doi: 10.1093/jn/136.4.887. [PubMed:16549446 ]
- Matsumura T, Kato T, Sugiyama N, Tasaka-Fujita M, Murayama A, Masaki T, Wakita T, Imawari M: 25-Hydroxyvitamin D3 suppresses hepatitis C virus production. Hepatology. 2012 Oct;56(4):1231-9. doi: 10.1002/hep.25763. [PubMed:22487892 ]
- Thienpont LM, Stepman HC, Vesper HW: Standardization of measurements of 25-hydroxyvitamin D3 and D2. Scand J Clin Lab Invest Suppl. 2012;243:41-9. doi: 10.3109/00365513.2012.681950. [PubMed:22536761 ]
- Jones AP, Palmer D, Zhang G, Prescott SL: Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy. Pediatrics. 2012 Nov;130(5):e1128-35. doi: 10.1542/peds.2012-1172. Epub 2012 Oct 22. [PubMed:23090338 ]
- de Brito Galvao JF, Nagode LA, Schenck PA, Chew DJ: Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease. J Vet Emerg Crit Care (San Antonio). 2013 Mar-Apr;23(2):134-62. doi: 10.1111/vec.12036. [PubMed:23566108 ]
|
---|